Antibiotice Iasi Strengthens Its International Growth: Sales Increase In The US, Entry Into Spanish Market

today, 13:06 By Ecaterina Craciun

Antibiotice Iasi (stock symbol: ATB), the largest Romanian owned drug maker, on Friday (June 5) released a report containing new details regarding its international expansion strategy, as it counts on a 25% increase in sales in the United States in 2026, after its main distributor in the US successfully completed ,at the end of May 2026 the audit carried out at the company's production facilities in lasi.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Antibiotice Iasi
, International Growth
, US
, Spanish Market